Molbio Diagnostics Ltd submits investor presentation reporting Q2 FY27 revenue of ₹259 crore, down 55.3% YoY
- Q2 revenue fell 36.5% sequentially from ₹408 crore; H1 FY27 revenue was ₹667 crore, down 1.9% YoY.
- Management attributed weaker Q2 performance to rate-contract negotiations.
- FY27 topline growth guidance reiterated at 25%.